Abiopharma

Insmed Strengthens Communities Worldwide During Fourth Annual Global Day of Good

Medicenna Therapeutics Reports Second Quarter Fiscal 2026 Financial Results and Provides a Corporate Update

Adagene Announces Licensing Agreement with Third Arc Bio for Development of Two Masked CD3 T Cell Engagers Utilizing SAFEbody® Technology

Century Therapeutics Announces New Beta Islet Program for Type 1 Diabetes

Venus Concept Announces Third Quarter 2025 Financial Results

Aura Biosciences Reports Third Quarter 2025 Financial Results and Business Highlights

Q32 Bio Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Protalix BioTherapeutics Reports Third Quarter 2025 Financial and Business Results

Duncan Regional Hospital Becomes First in U.S. to Implement BD Alaris™ EMR Infusion Interoperability with MEDITECH

Merck to Participate in the Jefferies Global Healthcare Conference in London